Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount
-
最新报道：Bristol-Myers Squibb and Pfizer announced a 40% discount on their blood thinner Eliquis for U.S. patients paying cash, aiming to improve affordability amid rising drug prices. The discount program, starting August 1, will apply to eligible patients without insurance or those whose plans don’t cover the medication. The companies emphasized their commitment to patient access while noting Eliquis remains a key revenue driver, generating $12 billion annually. The move follows increasing pressure on pharmaceutical firms to address high drug costs, though critics argue broader systemic reforms are needed. Both firms continue to explore additional patient assistance initiatives.
下一篇
Elate Holdings Issues $2.55 Million in Convertible Bonds for Web3 Expansion
- Elate Holdings has issued $2.55 million in convertible bonds to fund its Web3 expansion, a...
24小时热点
热点专题
407106